US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Palvella Therapeutics Inc (PVLA)
Palvella Therapeutics Inc (PVLA) オプション

Palvella Therapeutics Inc (PVLA)

114.82

-0.60

(-0.52%)

終了 6月5日 5:00AM

114.82

0.00

( 0.00% )

プレマーケット: 5:09PM

Palvella Therapeutics Inc ([symbol]) オプションチェーン

PVLA ライブオプションフロー

オプションコール

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
75.00	38.40	42.50	0.00	40.45	0.00	0.00 %	0	0	-
80.00	33.20	37.50	0.00	35.35	0.00	0.00 %	0	0	-
85.00	28.10	32.50	0.00	30.30	0.00	0.00 %	0	0	-
90.00	23.20	27.50	40.22	25.35	0.00	0.00 %	0	1	-
95.00	19.00	22.10	0.00	20.55	0.00	0.00 %	0	0	-
100.00	14.50	17.80	17.85	16.15	-0.45	-2.46 %	1	500	2026/6/04
105.00	10.00	13.50	19.00	11.75	0.00	0.00 %	0	1	-
110.00	7.00	10.10	0.00	8.55	0.00	0.00 %	0	0	-
115.00	4.00	7.90	6.07	5.95	0.07	1.17 %	2	35	2026/6/05
120.00	2.00	5.10	3.20	3.55	-0.40	-11.11 %	5	49	2026/6/05
125.00	0.50	4.90	2.35	2.70	0.00	0.00 %	0	1,096	-
130.00	0.05	4.00	2.80	2.025	0.00	0.00 %	0	1,008	-
135.00	0.30	4.90	5.20	2.60	0.00	0.00 %	0	100	-
140.00	0.00	4.90	5.00	5.00	0.00	0.00 %	0	11	-
145.00	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
150.00	0.00	1.20	4.50	4.50	0.00	0.00 %	0	250	-
155.00	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
160.00	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

オプションプット

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
75.00	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
80.00	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
85.00	0.00	2.55	0.00	0.00	0.00	0.00 %	0	0	-
90.00	0.00	4.90	2.55	2.55	0.00	0.00 %	0	4	-
95.00	0.10	4.90	2.95	2.50	0.00	0.00 %	0	1	-
100.00	0.10	4.90	4.94	2.50	0.00	0.00 %	0	21	-
105.00	0.75	3.60	2.50	2.175	-4.00	-61.54 %	2	53	2026/6/05
110.00	2.10	5.50	6.90	3.80	0.00	0.00 %	0	52	-
115.00	3.80	8.00	10.10	5.90	0.00	0.00 %	0	24	-
120.00	7.00	10.50	12.40	8.75	0.00	0.00 %	0	26	-
125.00	10.80	14.00	15.60	12.40	0.00	0.00 %	0	33	-
130.00	14.00	18.10	22.16	16.05	0.00	0.00 %	0	10	-
135.00	18.50	22.60	0.00	20.55	0.00	0.00 %	0	0	-
140.00	23.00	27.30	0.00	25.15	0.00	0.00 %	0	0	-
145.00	28.00	32.10	43.00	30.05	0.00	0.00 %	0	0	-
150.00	33.00	37.80	0.00	35.40	0.00	0.00 %	0	0	-
155.00	38.00	42.20	36.00	40.10	0.00	0.00 %	0	0	-
160.00	43.00	47.20	0.00	45.10	0.00	0.00 %	0	0	-

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
BGMSBio Green Med Solution Inc	US$ 2.6705 (151.93%)	5.67M
STISolidion Technology Inc	US$ 31.87 (40.33%)	1.99M
MTVAMetaVia Inc	US$ 3.32 (35.51%)	3.85M
SMTKSmartKem Inc	US$ 0.4261 (33.16%)	4.74M
DAICCID HoldCo Inc	US$ 3.99 (31.25%)	1.06M
INDPIndaptus Therapeutics Inc	US$ 3.18 (-33.05%)	73.67k
CYPHCypherpunk Technologies Inc	US$ 0.6699 (-31.74%)	509.81k
NYXHNyxoah SA	US$ 2.16 (-25.00%)	7.39k
LULGLeverage Shares 2X Long LULU Daily ETF	US$ 5.73 (-24.24%)	104.4k
WAITop KingWin Ltd	US$ 1.73 (-19.90%)	14
ZCMDZhongchao Inc	US$ 0.0328 (-9.39%)	26.09M
LHSWLianhe Sowell International Group Ltd	US$ 0.153 (-15.00%)	19.06M
YYGHYY Group Holding Ltd	US$ 0.1652 (1.98%)	9.91M
HKITHitek Global Inc	US$ 0.4186 (26.85%)	5.77M
BGMSBio Green Med Solution Inc	US$ 2.6705 (151.93%)	5.67M

$oldier Hard

$oldier Hard 2月前

$PVLA, nice job, keep it up

iHub News

iHub News 3月前

Palvella Therapeutics shares surge on positive Phase 3 trial resultsFebruary 24, 2026 10:20 AM
IH Market News
Palvella Therapeutics (NASDAQ:PVLA) shares climbed about 15% on Tuesday after the company announced positive topline data from its Phase 3 SELVA clinical trial evaluating QTORIN 3.9% rapamycin anhydrous gel for the treatment of microcystic lymphatic malformations (mLM).The late-stage study achieved its primary endpoint, demonstrating a statistically significant improvement on the Microcystic Lymphatic Malformation Investigator Global Assessment, with a mean change of +2.13 points (p

$oldier Hard

$oldier Hard 3月前

$PVLA there we go!

$oldier Hard

$oldier Hard 6月前

$PVLA, Steifel maintains buy on Palvella raises price target to $145.00

$oldier Hard

$oldier Hard 6月前

$PVLA, Raymond James upgraded the stock from outperform to strong buy and raised it's price target from $92.00 to $143.00.

$oldier Hard

$oldier Hard 7月前

$PVLA, more analysts upgrades up to $105.00 price target.

$oldier Hard

$oldier Hard 7月前

$PVLA, TD Cowen maintains buy on Palvella Therapeutics raises price target to $97.00

$oldier Hard

$oldier Hard 7月前

$PVLA, Cantor Fitzgerald maintains overweight on Palvella Therapeutics and raises price target to $200

ErnieBilco

ErnieBilco 7月前

Sold PVLA @ $77.38 for a cool 400%

$oldier Hard

$oldier Hard 8月前

$PVLA, wonder if we'll see another analyst upgrade after recent news?

$oldier Hard

$oldier Hard 8月前

$PVLA, still hummin along.

$oldier Hard

$oldier Hard 8月前

$PVLA, Stifel maintains buy and raises price target to $80.

$oldier Hard

$oldier Hard 9月前

$PVLA Canaccord Genuity raises PT to $66.00 from $52.00

$oldier Hard

$oldier Hard 11月前

PVLA headed towards first analyst price target. Still a ways to go but...

$oldier Hard

$oldier Hard 1年前

$PVLA, Scotia bank initiates coverage on PVLA with sector outperform rating price target $50.00.

$oldier Hard

$oldier Hard 1年前

$PVLA, analyst price target $39.00

$oldier Hard

$oldier Hard 1年前

$PVLA nice move today. Clear sailing ahead if they want.

$oldier Hard

$oldier Hard 2年前

$PIRS heavy volume day

Monksdream

Monksdream 2年前

$oldier Hard

$oldier Hard 2年前

$PIRS low O/S merger. Held on to a few of these just for giggles.

Monksdream

Monksdream 2年前

Renee

PIRS: Effective April 23,2024 a one for 80 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php

$oldier Hard

$oldier Hard 2年前

Mine went off at .265. Back on watch again.

Monksdream

Monksdream 2年前

Wash trade in progress

$oldier Hard

$oldier Hard 2年前

$PIRS no resistance up to .27 imo and a large gap above that.

glenn1919

glenn1919 2年前

PIRS...................................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783

Sjam410

Sjam410 3年前

Sjam410

Sjam410 3年前

Someone picked up a nice size at the close

Sjam410

Sjam410 3年前

Agreed. Picked up more shares today

Klinsmann

Klinsmann 3年前

Jep, nice consolidation and may explode again on further updates

Sjam410

Sjam410 3年前

Anyone still watching this?

Klinsmann

Klinsmann 3年前

There was one in the high 0.30´s, looks like it gets successfully taken down, but still could get rejected to 0.33 again. Gap in the high 0.70´s, and am not a pumper to talk about even more... I like this stock most because it takes every single step up perfectly and draws a perfect chart!

Nextbigone

Nextbigone 3年前

What resistance levels $1-1.20?

Klinsmann

Klinsmann 3年前

Break that resistance and we gonna have the best play of the month…

Klinsmann

Klinsmann 3年前

Hope some of you loaded with me under 0.25. It’s go time, support at the 50ma, maybe it’s possible to go for the 0.40 break this week…

Klinsmann

Klinsmann 3年前

Break these 0.40‘s to the 0.78 gap. On the expected updates everything possible…

glenn1919

glenn1919 3年前

PIRS....................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783

The Truth Hurts

The Truth Hurts 3年前

Interesting news. https://www.otcmarkets.com/stock/PIRS/news/story?e&id=2608442

Klinsmann

Klinsmann 3年前

Time for the final loading before the big bang...

Klinsmann

Klinsmann 3年前

They got a patent renewed - but still no real PR on it while similar stocks moved 100%+ on it. Still holding…

budapestjs

budapestjs 3年前

Hey, are you able to share what the patent news is that you mentioned?

Klinsmann

Klinsmann 3年前

Golden opp.here - patent news and still under radar

glenn1919

glenn1919 3年前

PIRS.........................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783

Triple nickle

Triple nickle 3年前

$oldier Hard

$oldier Hard 3年前

$PIRS nice 70% pop!

Triple nickle

Triple nickle 3年前

glenn1919

glenn1919 3年前

PIRS.....................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 3年前

PIRS......................https://stockcharts.com/h-sc/ui?s=PIRS&p=W&b=5&g=0&id=p86431144783

TheFinalCD

TheFinalCD 3年前

PIRS .20 https://finance.yahoo.com/news/were-little-worried-pieris-pharmaceuticals-142856056.html

willlbone

willlbone 3年前

Palvella Therapeutics

Compagnie Chargeurs Invest

Kasbah Resources

Datang International Pow...

Icahn Enterprises

Innovator ETFs T

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。